Stephen Webster

HearUSA, Inc. distributes audio-logical products and provides hearing impaired services. The company provides hearing care to patients primarily through its company-owned hearing care centers, which offers a complete range of quality hearing aids, with an emphasis on the latest digital technology. It provides hearing care to patients whose health insurance and Managed-care organizations have contracted with the company for such care and to retail self-pay patients. It offers hearing related products, such as batteries, hearing aid accessories and assistive listening devices online through its website. The Company operates two business segments: Center and Network segments. The Center segment offers patients a complete range of hearing care services and products, including diagnostic audiologic testing, the latest technology in hearing aids and assistive listening devices to improve their quality of life. The Network segment sponsors a network of credentialed audiology providers that supports hearing benefit programs with employer groups, health insurers and benefit sponsors. Through the network, the company can pursue national hearing care contracts and offer managed hearing benefits in areas outside of the company-owned center markets. HearUSA was founded on April 11, 1986 by Paul A Brown and is headquartered in West Palm Beach, FL.

Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA.

Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA.

Broadpoint.Gleacher Securities, formerly Broadpoint Capital, Inc. is an independent, institutional investment banking, sales and trading boutique headquartered in New York City. They were also previously known as First Albany Capital, Inc. The firm is a subsidiary of Broadpoint Securities Group, Inc. (Nasdaq: BPSG), formerly known as First Albany Cos., Inc. They have additional offices in Boston, Chicago, Denver, San Francisco, Bonita Springs, Florida, Glen Allen, Virginia, Roseland, New Jersey and St. Louis, Missouri. Broadpoint.Gleacher follows a range of fixed-income securities and provides proprietary views and analysis on credit fundamentals and trading dynamics. They focus on investment grade, high yield and convertible securities in the following sectors: consumer, building materials, financials, gaming / leisure, healthcare, homebuilding, industrials, mining, packaging, paper/forest products, power/energy, technology/media/telecommunications and transportation.

Part of Gleacher & Co., Inc., Broadpoint Securities, Inc. is a private company that provides broker-dealer and investment banking services. The company is based in New York, NY. Broadpoint Securities was acquired by BroadPoint Securities Group, Inc. on May 17, 2004 for $32 million.